Trends in the Use of Sexually Transmitted Disease Diagnostic Technologies in California, 1996–2003

Ahrens, Katherine A.; Bradbury, Keith; Bauer, Heidi M.; Samuel, Michael C.; Gould, Gail; Donatoni, Giannina; Higgins, Chandra; Kerndt, Peter R.; Bolan, Gail

doi:10.1097/01.olq.0000253346.41123.7c

Cited by 10 publications

(7 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A survey of laboratories in the District of Columbia that reported gonorrhea results to the health department demonstrated that among laboratories that conducted gonorrhea cultures, only one third performed antibiotic susceptibility testing (51). A study of clinical laboratories in California reported that gonorrhea culture testing has substantially decreased and gonorrhea and chlamydia tests performed using NAAT have increased over time (52). For detection of herpes simplex virus (HSV), direct antigen and culture testing on lesions have decreased over time and serologic testing has increased (52).…”

Section: Current Practice On Selected Clinical Services In the Unitedmentioning

confidence: 99%

“…A study of clinical laboratories in California reported that gonorrhea culture testing has substantially decreased and gonorrhea and chlamydia tests performed using NAAT have increased over time (52). For detection of herpes simplex virus (HSV), direct antigen and culture testing on lesions have decreased over time and serologic testing has increased (52).…”

Section: Current Practice On Selected Clinical Services In the Unitedmentioning

confidence: 99%

See 1 more Smart Citation

Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services, 2020

Barrow¹,

Ahmed²,

Bolan³

et al. 2020

MMWR Recomm. Rep.

103

View full text Add to dashboard Cite

This report (hereafter referred to as STD QCS) provides CDC recommendations to U.S. health care providers regarding quality clinical services for sexually transmitted diseases (STDs) for primary care and STD specialty care settings. These recommendations complement CDC's Sexually Transmitted Diseases Treatment Guidelines, 2015 (hereafter referred to as the STD Guidelines), a comprehensive, evidence-based reference for prevention, diagnosis, and treatment of STDs. STD QCS differs from the STD Guidelines by specifying operational determinants of quality services in different types of clinical settings, describing on-site treatment and partner services, and indicating when STD-related conditions should be managed through consultation with or referral to a specialist. These recommendations might also help in the development of cliniclevel policies (e.g., standing orders, express visits, specimen panels, and reflex testing) that can facilitate implementation of the STD Guidelines. CDC organized the recommendations for STD QCS into eight sections: 1) sexual history and physical examination, 2) prevention, 3) screening, 4) partner services, 5) evaluation of STD-related conditions, 6) laboratory, 7) treatment, and 8) referral to a specialist for complex STD or STD-related conditions. CDC developed the recommendations by synthesizing relevant, evidence-based guidelines and recommendations issued by other experts; reviewing current practice in the United States; soliciting Delphi ratings by subject matter experts on STD care in primary care and STD specialty care settings; discussing the scientific evidence supporting the proposed recommendations at a consultation meeting of experts and institutional stakeholders held November 20, 2015, in Atlanta, Georgia; conducting peer reviews of draft recommendations and supporting evidence; and discussing draft recommendations and supporting evidence during meetings of the CDC/Health Resources and Services Administration Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment STD Work Group. These recommendations are intended to help health care providers in primary care or STD specialty care settings offer STD services at their clinical settings and to help the persons seeking care live safer, healthier lives by preventing and treating STDs and related complications.

show abstract

Section: Current Practice On Selected Clinical Services In the Unitedmentioning

confidence: 99%

Section: Current Practice On Selected Clinical Services In the Unitedmentioning

confidence: 99%

Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services, 2020

Barrow¹,

Ahmed²,

Bolan³

et al. 2020

MMWR Recomm. Rep.

103

View full text Add to dashboard Cite

show abstract

“…In California, the proportion of gonorrhea testing performed using PCR test increased from 1-59% and culture test decreased from 42-10% of all gonorrhea testing. [34] In contrast, the availability of PCR test was still as low as 15% among hospitals providing STI clinical service in Shandong province in 2018.…”

Section: Discussionmentioning

confidence: 99%

Availability of laboratory diagnosis of gonorrhoea and its meaning in case reporting in Shandong province, China

Chen¹,

Gan²,

Liu

2020

Preprint

View full text Add to dashboard Cite

Abstract Background The aim of this study is to understand the availability of laboratory diagnosis of gonorrhoea in Shandong province and its meaning in case reporting. Methods Two surveys were conducted among hospitals providing clinical services for sexually transmitted infection(STI) in Shandong Province in 2012 and 2018. The availability of laboratory tests for Neisseria gonorrhoeae (NG) and distribution of reported gonorrhea cases were compared among different hospitals provided clinical services for STI in Shandong province. Descriptive analysis and Chi-square were used for statistical analysis. Results Smear, culture and PCR tests for NG were used among 301(74.69%), 123(30.52%), 43(10.67%) hospitals in 2012 and 356(74.48%), 176(36.82%) and 73(15.27%) hospitals in 2018, respectively. Significant differences were observed in the availability of smear among hospitals at different levels (X2 = 12.159, p = 0.000) and with different affiliations(X2 = 4.551, p = 0.033) in 2018. Significant differences were observed in the availability of culture and PCR tests among hospitals at different levels both in 2012 (X2 = 34.532, p = 0.000; X2 = 7.380, p = 0.007) and 2018 (X2 = 49.820, p = 0.000; X2 = 21.658, p = 0.000). The availability of culture and PCR tests for NG among hospitals in 2018 was higher than that in 2012 (X2 = 3.870, p = 0.049; X2 = 4.050, p = 0.044). More hospitals reported gonorrhea cases in 2018 than in 2012 (X2 = 6.768, p = 0.009). A significant difference was observed in distribution of case reporting among hospitals at different levels in 2018 (X2 = 6.975, p = 0.008) and among different types of hospitals both in 2012 (X2 = 52.362, p = 0.000) and 2018 (X2 = 74.478, p = 0.000). Conclusion Poor availability of NG laboratory tests affects case reporting and is a crucial reason leading to high sex ratio and underreporting of gonorrhea cases in Shandong province. Trial registration Not applicable

show abstract

“…Monitoring trends in the use of diagnostic methods enhances STI control efforts by improving the interpretation of STI trends, creating valuable partnerships with laboratories, facilitating the evaluation of screening programs and investigating outbreaks [28]. With the continuous development and improvement of diagnostic methods it is obvious that there have been changes since this survey was performed.…”

Section: Discussionmentioning

confidence: 99%

Highly variable use of diagnostic methods for sexually transmitted infections-results of a nationwide survey, Germany 2005

et al. 2010

View full text Add to dashboard Cite

BackgroundSexual transmitted infections (STIs) have increased in Germany and other countries in Europe since the mid-nineties. To obtain a better picture of diagnostic methods used in STI testing institutions in Germany, we performed a nationwide survey amongst STI specialists in order to evaluate the quality of STI reports and provide recommendations to harmonize and possibly improve STI diagnostics in Germany.MethodsWe asked sentinel physicians and randomly chosen gynaecologists, urologists and dermato-venerologists, about the diagnostic methods used in 2005 to diagnose HIV, chlamydia (CT), gonorrhoea (GO) and syphilis (SY) in a national cross-sectional survey in order to recognize potential problems and provide recommendations.ResultsA total of 739/2287 (32%) physicians participated. Of all participants, 80% offered tests for HIV, 84% for CT, 83% for GO and 83% for SY. Of all participants who performed HIV testing, 90% requested an antibody test, 3% a rapid test and 1% a nucleic acid amplification test (NAAT). For CT testing, NAAT was used in 33% and rapid tests in 34% of participants. GO resistance testing was performed by 31% of the participants. SY testing was performed in 98% by serology.ConclusionsDiagnostic methods for STI vary highly among the participants. Diagnostic guidelines should be reviewed and harmonised to ensure consistent use of the optimal STI diagnostic methods.

show abstract

Trends in the Use of Sexually Transmitted Disease Diagnostic Technologies in California, 1996–2003

Abstract: Analyzing trends in diagnostic technologies enhances our understanding of the epidemiology of STDs and monitoring laboratory capacity and practices facilitates implementation of STD control activities.

Cited by 10 publications

References 11 publications

Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services, 2020

Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services, 2020

Availability of laboratory diagnosis of gonorrhoea and its meaning in case reporting in Shandong province, China

Highly variable use of diagnostic methods for sexually transmitted infections-results of a nationwide survey, Germany 2005

Contact Info

Product

Resources

About